€4.8m EU-Funded AI Project to Tackle Child Diarrhoeal Disease in Africa

Key Takeaways

• EU funds $5.2 M AI tool for child diarrhoea in sub‑Saharan Africa.
• Tool predicts pathogen and antibiotic resistance in five minutes on a tablet.
• Pilot in eight clinics, scaling to 40 sites and 4,700 children.
• Combines clinical, climate, socioeconomic data to improve diagnosis accuracy.
• Aims to curb antimicrobial resistance by reducing unnecessary antibiotic prescriptions.

Pulse Analysis

Diarrhoeal disease remains one of the top causes of mortality among children under five, especially in sub‑Saharan Africa where limited diagnostic capacity forces clinicians to rely on broad‑spectrum antibiotics. The European Union’s €4.8 million (approximately $5.2 million) CARE‑AFRICA grant seeks to change that calculus by delivering a point‑of‑care artificial‑intelligence solution. Led by King’s College London, the consortium blends expertise from the UK, Italy, Spain, South Africa, Uganda and Ethiopia, reflecting a growing trend of cross‑border collaborations that marry cutting‑edge machine‑learning with public‑health priorities in low‑resource settings.

The AI engine will be trained on a rich dataset that merges clinical records from Ethiopian and Ugandan children with environmental, climate and socioeconomic variables linked to pathogens such as Shigella, Vibrio cholerae, Escherichia coli and norovirus. When a health worker inputs a child’s symptoms on a tablet, the model returns probability scores for each likely pathogen, flags known antibiotic‑resistance patterns and suggests the most appropriate therapy—all within five minutes. An eight‑site pilot in Ethiopia and Uganda will validate accuracy against standard care before the system is expanded to 40 facilities and roughly 4,700 patients.

If the tool proves reliable, it could slash unnecessary antibiotic use, a key driver of antimicrobial resistance, while accelerating life‑saving treatment for vulnerable children. Faster, data‑driven diagnoses also ease the burden on overstretched clinics, allowing limited staff to focus on severe cases. The project exemplifies how AI can be operationalized beyond research labs, offering a scalable template for other infectious‑disease challenges in low‑and middle‑income countries. Success would reinforce the EU’s strategic investment in health‑tech innovation and could attract further funding for similar digital health interventions.